Canada Markets closed

InnoCan Pharma Corporation (INNO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2550+0.0050 (+2.00%)
At close: 09:30AM EDT
Full screen
Previous Close0.2500
Open0.2550
Bid0.2550 x N/A
Ask0.2700 x N/A
Day's Range0.2550 - 0.2550
52 Week Range0.1950 - 0.6800
Volume16,100
Avg. Volume31,672
Market Cap63.653M
Beta (5Y Monthly)3.71
PE Ratio (TTM)N/A
EPS (TTM)-0.0750
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma Product

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative wellness products, announced today the successful results of a controlled efficacy test (the "Trial") regarding its vaginal derma product (the "Product").The results of the Trial demonstrate that Innocan's Product, which contains cannabinoids, phytoestrogens, h

  • Baystreet

    Stocks in play: InnoCan Pharma Corp

    Announces the launch of its licensing and commercialization strategy work with respect to cannabinoid ...

  • Newsfile

    Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 17, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a proprietary IP portfolio, is excited to announce the launch of its licensing and commercialization strategy work with respect to cannabinoid (CBD) therapy in the veterinary field.Innocan CEO, Iris Bincovich, s